ESR1 and breast cancer: Specifically, we reported that leptin is able to activate ERα transcriptionally through MAPK pathway in breast cancer cells in the absence of its natural ligand, reproducing the classic features of ERα transactivation, such as nuclear localization, down-regulation of its mRNA and protein levels, and up-regulation of classic estrogen-dependent genes (26).